Clinical Trial

Small Cell Lung Cancer Community Engagement to Eliminate Research Discepancies

Study acronym: SUCCEED
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
This study will evaluate if a direct-to-patient, de-centralized, remote approach will improve clinical research outreach and engagement for patients with SCLC, in the context of a bio-specimen collection study. The study will also assess self-reported preferences and needs of patients with SCLC, regarding choosing and accessing novel therapies in research or standard clinical care settings and supportive gaps in this area, through an initial and 3 month follow up survey.
Protocol Amendment History 4 changes
critical Enrollment closed, study ongoing 2026-08-05
notable Enrollment reduced: 30 -> 22 participants 2026-08-05
notable Primary completion moved earlier: 2026-12 -> 2026-07-15 2026-08-05
minor Completion moved earlier: 2027-06 -> 2026-12 2026-08-05
Trial Details
NCT Number NCT06486428
Lead Sponsor Addario Lung Cancer Medical Institute
Conditions Small-cell Lung Cancer
Enrollment 22 participants
Start Date 2025-05-23
Primary Completion 2026-07-15 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2026-08-04